Cite
Inomata M, Hayashi R, Yamamoto A, et al. Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib. Mol Clin Oncol. 2015;3(4):802-806doi: 10.3892/mco.2015.568.
Inomata, M., Hayashi, R., Yamamoto, A., Tokui, K., Taka, C., Okazawa, S., Kambara, K., Suzuki, K., Ichikawa, T., Yamada, T., Miwa, T., Kashii, T., Matsui, S., Tobe, K., & Imura, J. (2015). Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib. Molecular and clinical oncology, 3(4), 802-806. https://doi.org/10.3892/mco.2015.568
Inomata, Minehiko, et al. "Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib." Molecular and clinical oncology vol. 3,4 (2015): 802-806. doi: https://doi.org/10.3892/mco.2015.568
Inomata M, Hayashi R, Yamamoto A, Tokui K, Taka C, Okazawa S, Kambara K, Suzuki K, Ichikawa T, Yamada T, Miwa T, Kashii T, Matsui S, Tobe K, Imura J. Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib. Mol Clin Oncol. 2015 Jul;3(4):802-806. doi: 10.3892/mco.2015.568. Epub 2015 May 14. PMID: 26171184; PMCID: PMC4486842.
Copy
Download .nbib